Michael Scolaro

Michael Scolaro

Oct 06, 2017

Group 6 Copy 217
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Building an active surveillance system for lead in Northeastern wildlife

Many species of wildlife are exposed to lead in the environment, sometimes with devastating consequences...

Finding a Cure for Batten Disease

In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...

Backer Badge Funded